Jim Joyce Chairman, CEO January 9, 2012 My presentation may contain predictions, estimates, and other forward looking statements that involve risks and uncertainties, including whether and when our products are successfully developed and introduced, market acceptance of the Aethlon ADAPT™ system, the Hemopurifier® and other product offerings, regulatory delays, manufacturing delays, and other risks detailed in our sec filings accessible at www. Sec.gov.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Jim Joyce Chairman, CEO January 9, 2012
My presentation may contain predictions, estimates, and other forward looking statements that involve risks and uncertainties, including whether and when our products are successfully developed and introduced, market acceptance of the Aethlon ADAPT™ system, the Hemopurifier® and other product offerings, regulatory delays, manufacturing delays, and other risks detailed in our sec filings accessible at www. Sec.gov.
We create medical devices to address unmet medical needs in cancer, infectious disease, and other life-threatening conditions
The transition from development-stage to revenue-stage organization